Abstract: The present invention is directed to peptides, and nucleic acids encoding them, derived from the Hepatitis C Virus (HCV). The peptides are those which elicit a CTL and/or HTL response in a host. The invention is also directed to compositions and vaccines for prevention and treatment of HCV infection and diagnostic methods for detection of HCV exposure in patients.
Type:
Application
Filed:
October 6, 2009
Publication date:
April 22, 2010
Applicants:
GENIMMUNE, PHARMEXA INC.
Inventors:
Marie-Ange Buyse, Geert Maertens, Erik Depla, Ignace Lasters, Johan Desmet, Denise Baker, Robert W. Chesnut, Mark Newman, Alessandra Sette, John Sidney, Scott Southwood